Skip to main content

Advertisement

SpringerLink
Log in

Further notice of omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation

  • Letter to the Editor
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

  • 1 Altmetric

The Original Article was published on 31 December 2022

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tanaka Y, Yamashita R, Kawashima J, et al. Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation. J Gastroenterol. 2022;57:748–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Wang J, Tao L, Chen M. The role of sex hormones in the fecal microbiota of IBS-D patients with exacerbation of symptoms deserves attention. J Gastroenterol. 2022. https://doi.org/10.1007/s00535-022-01950-z

    Article  PubMed  PubMed Central  Google Scholar 

  3. Fukudo S. Hypothalamic-pituitary-adrenal axis in gastrointestinal physiology. Chapter 28, Section II: neurogastroenterology. In: Johnson L, editor. Physiology of the gastrointestinal tract. 5th ed. Cambridge: Elsevier; 2012. p. 795–815.

    Google Scholar 

  4. Tanaka Y, Kanazawa M, Kano M, et al. Differential activation in amygdala and plasma noradrenaline during colorectal distention by administration of corticotropin-releasing hormone between healthy individuals and patients with irritable bowel syndrome. PLoS One. 2016;11: e0157347.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Vervier K, Moss S, Kumar N, et al. Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet. Gut. 2022;71:1821–30.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was supported by JSPS KAKENHI Grant Number 17K17584, 16H06279 (PAGS), 19K22589, SRF, JST ERATO JPMJER1902, AMED-CREST JP21gm1010009, the Food Science Institute Foundation, Astellas Foundation for Research on Metabolic Disorders, and Kato Memorial Bioscience Foundation. This work was partly performed in the Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University.

Author information

Author notes

  1. Yukari Tanaka and Riu Yamashita are first authors.

Authors and Affiliations

  1. Department of Gastroenterology, Sendai Kousei Hospital, Sendai, Japan

    Yukari Tanaka

  2. Behavioral Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan

    Yukari Tanaka & Shin Fukudo

  3. Division of Translational Informatics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan

    Riu Yamashita

  4. Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan

    Junko Kawashima

  5. Advanced Genomics Center, National Institute of Genetics, Shizuoka, Japan

    Hiroshi Mori & Ken Kurokawa

  6. Institute for Advanced Biosciences, Keio University, Yamagata, Japan

    Shinji Fukuda

  7. Gut Environmental Design Group, Kanagawa Institute of Industrial Science and Technology, Kanagawa, Japan

    Shinji Fukuda

  8. Transborder Medical Research Center, University of Tsukuba, Ibaraki, Japan

    Shinji Fukuda

  9. Department of Bacteriology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan

    Yasuhiro Gotoh, Keiji Nakamura & Tetsuya Hayashi

  10. Department of Fetal and Maternal Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan

    Yoshiyuki Kasahara

  11. Center for Strategic Research Project, University of the Ryukyus, Nishihara, Okinawa, Japan

    Yukuto Sato

Authors
  1. Yukari Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Riu Yamashita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Junko Kawashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroshi Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ken Kurokawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shinji Fukuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yasuhiro Gotoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Keiji Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tetsuya Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yoshiyuki Kasahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yukuto Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Shin Fukudo
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YT and RY are equally contributing first authors. YT and RY designed the study. YT, RY and JK performed the study and analyzed the data. RY, HM, KK, SF, YG, KN, TH, YK, and YS provided the measurements for the microbiome and metabolome analysis. SFukudo provided scientific insight to complete the study. YT wrote the first draft of the manuscript. SFukudo prepared the final version of the manuscript. All authors contributed to data interpretation, writing, and final approval of the manuscript.

Corresponding author

Correspondence to Shin Fukudo.

Ethics declarations

Conflict of interest

All authors declare that there are no conflicts of interest in this research.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tanaka, Y., Yamashita, R., Kawashima, J. et al. Further notice of omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation. J Gastroenterol 58, 427–428 (2023). https://doi.org/10.1007/s00535-022-01951-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-022-01951-y

Search

Navigation